As mitochondrial dynamics is emerging as a potential new therapeutic target for heart failure,56 the scaffolding activity offered by Anxa6 holds much promise as a positive regulator of mitochondrial dynamics in hypertrophied cardiomyocytes. The gene discussed is ANXA6; the disease is heart failure.